This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Institut Pasteur. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5,383 
1 out of 898 
Years Active: 2011
Title: Mohammed El-Azami El-Idrissi: Innovator in Pharmaceutical Composition
Introduction
Mohammed El-Azami El-Idrissi is a notable inventor from Morocco, recognized for his contributions to the field of pharmaceutical compositions. His innovative work focuses on modified adenylate cyclase toxins, which have significant implications for treating whooping cough and protecting against infections.
Latest Patents
El-Azami El-Idrissi holds 1 patent related to his invention, which involves modified adenylate cyclase toxins that are deficient in CD11b/CD18 binding. This invention also encompasses specific fragments of adenylate cyclase that include the CD11b/CD18 interaction domain, aimed at targeting molecules of interest to CD11b expressing cells.
Career Highlights
Throughout his career, El-Azami El-Idrissi has worked with prestigious institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. His work in these organizations has contributed to advancements in medical research and pharmaceutical development.
Collaborations
El-Azami El-Idrissi has collaborated with esteemed colleagues, including Claude Leclerc and Daniel Ladant, further enhancing the impact of his research and inventions.
Conclusion
Mohammed El-Azami El-Idrissi's innovative contributions to pharmaceutical compositions highlight his role as a significant inventor in the field. His work continues to influence advancements in medical treatments and research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile